SLC5A2 and kidney neoplasm: Kaplan-Meier analyses for Sglt2-Cre; ASPSCR1-TFE3LSL/+ mice that exclusively developed kidney tumors showed a median survival of 13.5 months (P < 0.0001) (Figure 4B and Table 1).